Cargando…
miR-802 inhibits the aggressive behaviors of non-small cell lung cancer cells by directly targeting FGFR1
Autores principales: | Zhang, Jiexia, Li, Jun, Li, Shiyue, Zhou, Chengzhi, Qin, Yinyin, Li, Xiaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291249/ https://www.ncbi.nlm.nih.gov/pubmed/35796016 http://dx.doi.org/10.3892/ijo.2022.5389 |
Ejemplares similares
-
Dysfunction of miR‐802 in tumors
por: Gao, Tong, et al.
Publicado: (2021) -
Retraction: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
Publicado: (2023) -
miR-663 promotes NPC cell proliferation by directly targeting CDKN2A
por: Liang, Shaoqiang, et al.
Publicado: (2022) -
miR-140-5p Alleviates The Aggressive Progression Of Wilms’ Tumor Through Directly Targeting TGFBR I Gene [Retraction]
Publicado: (2019) -
miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer
por: Hou, Yan, et al.
Publicado: (2021)